about
Inflammatory bowel disease and celiac disease: overlaps and differences.Safety and Efficacy of Adalimumab for Patients With Moderate to Severe Crohn's Disease: The Taiwan Society of Inflammatory Bowel Disease (TSIBD) Study.From historical perspectives to modern therapy: a review of current and future biological treatments for Crohn's diseasePharmacokinetics and toxicology of therapeutic proteins: Advances and challenges.Impact of physiochemical properties on pharmacokinetics of protein therapeutics.Is there a role for vedolizumab in the treatment of ulcerative colitis and Crohn's disease?Role of biologics and biosimilars in inflammatory bowel disease: current trends and future perspectives.
P2860
Q33564085-5C16DF90-4EFE-4240-8D57-4EBBB71D888AQ34429618-C58F0100-3471-4046-BA57-3A8E252A8343Q35559305-2BE5C440-2396-4C81-A692-1456459B59D8Q35929084-34219CFE-4C3B-495E-B7BB-59B31CD2BAB8Q38098934-4D678672-5809-494E-B7C9-F1856F3CC999Q38217832-E5CD4A8D-4274-4124-9858-45ED31D71299Q54961768-BAA7E066-AC0E-426D-AA8E-9AEFEE31B550
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Efficacy and safety of adalimumab in Crohn's disease
@ast
Efficacy and safety of adalimumab in Crohn's disease
@en
Efficacy and safety of adalimumab in Crohn's disease
@nl
type
label
Efficacy and safety of adalimumab in Crohn's disease
@ast
Efficacy and safety of adalimumab in Crohn's disease
@en
Efficacy and safety of adalimumab in Crohn's disease
@nl
prefLabel
Efficacy and safety of adalimumab in Crohn's disease
@ast
Efficacy and safety of adalimumab in Crohn's disease
@en
Efficacy and safety of adalimumab in Crohn's disease
@nl
P2860
P356
P1476
Efficacy and safety of adalimumab in Crohn's disease
@en
P2093
Gary R Lichtenstein
Remo Panaccione
P2860
P356
10.1177/1756283X08092548
P577
2008-07-01T00:00:00Z